Terms ending in 2034
Every in-force patent on Givaudan S.A.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,121,836 | Retronasal Device And Method In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 11,832,638 | N-Acyl Derivatives of Gamma Amino - Butyric Acid and Beta Alanine as Food Flavouring Compounds In force · Low confidence | Givaudan S.A. | In force | Low confidence | |
| US 9,480,280 | Taste Modifiers In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 9,656,938 | Organic Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 9,988,592 | Organic Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 10,457,891 | Organic Compounds In force · Medium confidence | Givaudan S.A. | In force | Medium confidence | |
| US 9,469,590 | Improvements in or Relating to Organic Compounds In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 10,315,976 | Organic Compounds In force · Medium confidence | Givaudan SA | In force | Medium confidence | |
| US 10,537,127 | Organic Compounds In force · High confidence | Givaudan S.A. | In force | High confidence | |
| US 9,708,570 | Organic Compounds In force · High confidence | Givaudan S.A. | In force | High confidence | |
| 9 more term ends in 2034 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.